Lisa Sanford

Statistics

Publications

Citations

814

H-Index

Active since

1994

Affiliations

Research Triangle Park Foundation(Current)

GlaxoSmithKline (United Kingdom)

GlaxoSmithKline (United States)

Baylor College of Medicine

Lisa Sanford is an author at Research Triangle Park Foundation specializing in pharmacotherapy, pulmonology, and chronic obstructive pulmonary disease.

Publications per year

1994–2013

Publications

Once-daily inhaled fluticasone furoate and vilanterol versus vilanterol only for prevention of exacerbations of COPD: two replicate double-blind, parallel-group, randomised controlled trials

Mark T. Dransfield, Jean Bourbeau, Paul Jones et al. · The Lancet Respiratory Medicine · 2013 · 359 citations

Medicine, Internal Medicine, Pharmacotherapy +13

Severe polyethylene wear in total hip arthroplasty

James V. Bono, Lisa Sanford, Jon T. Toussaint · The Journal of Arthroplasty · 1994 · 145 citations

Medicine, Orthopaedic Surgery, Orthopedic Surgery +13

A randomised trial of fluticasone furoate/vilanterol (50/25 μg; 100/25 μg) on lung function in COPD

Edward Kerwin, Catherine Scott-Wilson, Lisa Sanford et al. · Respiratory Medicine · 2013 · 117 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +11

The Efficacy and Safety of the Novel Long-Acting β2 Agonist Vilanterol in Patients With COPD

Nicola A. Hanania, Gregory Feldman, W. Zachgo et al. · CHEST Journal · 2012 · 105 citations

Medicine, Pharmacology, Pharmacotherapy +14

Effect of Once-Daily Fluticasone Furoate/Vilanterol on 24-Hour Pulmonary Function in Patients With Chronic Obstructive Pulmonary Disease: A Randomized, Three-Way, Incomplete Block, Crossover Study

Joseph Boscia, Krishna Pudi, Michael T. Zvarich et al. · Clinical Therapeutics · 2012 · 48 citations

Medicine, Pharmacology, Pharmacotherapy +17

1–5 of 6